fda approved glp 1 approves Foundayo, an oral GLP-1 alternative to Wegovy and Ozempic FDA Approves Oral Semaglutide: First
Description
Weekly trend is also easy to overread

It plans to launch the medicine in early January and will offer a cash price of $149 a month for the starting dose of the medicine

The counter-argument is that mechanistic evidence is strong, multiple lines of clinical evidence converge, and the risk profile at microdose levels is favorable

Unlike stimulant-heavy diet pills or restrictive detox products, it focuses on the body's own hormonal pathways, specifically GLP-1 (glucagon-like peptide-1) activity, to encourage satiety, stabilize energy, and promote long-term metabolic health
